Page last updated: 2024-09-02

1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Edema, Pulmonary

1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with Edema, Pulmonary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giaid, A; Kuang, JQ; Ohlstein, EH; Shennib, H1

Other Studies

1 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Edema, Pulmonary

ArticleYear
Endothelin receptor antagonist improves pulmonary hemodynamics during lung ischemia/reperfusion injury.
    Transplantation, 1998, Oct-15, Volume: 66, Issue:7

    Topics: Animals; Blood Pressure; Cold Temperature; Endothelin Receptor Antagonists; Hemodynamics; Indans; Ischemia; Lung Compliance; Oxygen; Partial Pressure; Pulmonary Artery; Pulmonary Circulation; Pulmonary Edema; Rabbits; Reperfusion Injury; Vascular Resistance

1998